2016 - Fellow of the American Association for the Advancement of Science (AAAS)
His primary areas of investigation include Molecular biology, Ubiquitin, Immunology, Endothelium and Internal medicine. His Molecular biology research includes elements of Microphthalmia-associated transcription factor, Transcription factor, Ubiquitin-conjugating enzyme and Cell biology. His study in Cell biology focuses on Myocyte in particular.
His study in Ubiquitin is interdisciplinary in nature, drawing from both Proteases, BCL2-related protein A1 and Northern blot. His research in Endothelium intersects with topics in Endothelial stem cell, Cytokine, Cell adhesion molecule, Monocyte and Umbilical vein. The concepts of his Internal medicine study are interwoven with issues in Endocrinology and Cardiology.
Edward T.H. Yeh focuses on Cell biology, Internal medicine, Molecular biology, SUMO protein and Biochemistry. His Cell biology research focuses on subjects like Endothelial stem cell, which are linked to Endothelium and Cell adhesion molecule. His biological study spans a wide range of topics, including Endocrinology, Oncology and Cardiology.
The Molecular biology study combines topics in areas such as Origin recognition complex, Eukaryotic DNA replication, Control of chromosome duplication, Histone and Gene silencing. His work investigates the relationship between SUMO protein and topics such as Proteases that intersect with problems in Signal transduction. His Heart failure research is multidisciplinary, incorporating perspectives in Cancer, Chemotherapy and Intensive care medicine.
Edward T.H. Yeh mainly investigates Internal medicine, Cardiotoxicity, Cancer, Cell biology and Intensive care medicine. Edward T.H. Yeh combines subjects such as Endocrinology, Isocitrate dehydrogenase and Cardiology with his study of Internal medicine. His Cardiotoxicity study is concerned with Chemotherapy in general.
The Cancer study combines topics in areas such as Surgery, Heart failure, Oncology, MEDLINE and Immunology. His Cell biology study incorporates themes from SUMO protein and Receptor. As a part of the same scientific family, Edward T.H. Yeh mostly works in the field of Ubiquitin, focusing on Regulation of gene expression and, on occasion, Molecular biology.
His main research concerns Cardiotoxicity, Intensive care medicine, Internal medicine, Anthracycline and Cardiology. His Intensive care medicine research incorporates themes from Cardiovascular Complication, Cardiomyopathy, Disease management and Cancer. He has researched Cardiovascular Complication in several fields, including Targeted therapy, Pericardium, Radiation therapy and Atrial fibrillation.
His research in Cancer intersects with topics in Bioinformatics and Pathology. His Internal medicine study is mostly concerned with Cardioprotection, Troponin I, Chemotherapy, Ejection fraction and Cardiac imaging. His Cardiology research is multidisciplinary, relying on both Anthracycline induced cardiotoxicity, Secondary prevention, Doxorubicin and Molecular targets.
This overview was generated by a machine learning system which analysed the scientist’s body of work. If you have any feedback, you can contact us here.
Direct Proinflammatory Effect of C-Reactive Protein on Human Endothelial Cells
Vincenzo Pasceri;Vincenzo Pasceri;James T. Willerson;James T. Willerson;Edward T. H. Yeh.
Modulation of C-Reactive Protein–Mediated Monocyte Chemoattractant Protein-1 Induction in Human Endothelial Cells by Anti-Atherosclerosis Drugs
Vincenzo Pasceri;Vincenzo Pasceri;Jed Chang;James T. Willerson;James T. Willerson;Edward T. H. Yeh.
Identification of the molecular basis of doxorubicin-induced cardiotoxicity
Sui Zhang;Xiaobing Liu;Xiaobing Liu;Tasneem Bawa-Khalfe;Long Sheng Lu.
Nature Medicine (2012)
Cardiovascular complications of cancer therapy: incidence, pathogenesis, diagnosis, and management.
Edward T.H. Yeh;Edward T.H. Yeh;Courtney L. Bickford.
Journal of the American College of Cardiology (2009)
Pml Is Critical for Nd10 Formation and Recruits the Pml-Interacting Protein Daxx to This Nuclear Structure When Modified by Sumo-1
Alexander M. Ishov;Alexey G. Sotnikov;Dmitri Negorev;Olga V. Vladimirova.
Journal of Cell Biology (1999)
Cardiovascular complications of cancer therapy: diagnosis, pathogenesis, and management.
Edward T.H. Yeh;Ann T. Tong;Daniel J. Lenihan;S. Wamique Yusuf.
Modulation of Vascular Inflammation In Vitro and In Vivo by Peroxisome Proliferator–Activated Receptor-γ Activators
Vincenzo Pasceri;Henry D. Wu;James T. Willerson;James T. Willerson;Edward T. H. Yeh.
Inflammatory cytokines stimulated C-reactive protein production by human coronary artery smooth muscle cells.
Paolo Calabró;James T. Willerson;Edward T.H. Yeh.
SUMO-Specific Protease 1 Is Essential for Stabilization of HIF1α during Hypoxia
Jinke Cheng;Jinke Cheng;Xunlei Kang;Xunlei Kang;Sui Zhang;Edward T.H. Yeh;Edward T.H. Yeh.
Radiation-related heart disease: current knowledge and future prospects.
Sarah C. Darby;David J. Cutter;Marjan Boerma;Louis S. Constine.
International Journal of Radiation Oncology Biology Physics (2010)
If you think any of the details on this page are incorrect, let us know.
We appreciate your kind effort to assist us to improve this page, it would be helpful providing us with as much detail as possible in the text box below: